Change over time of bowel habit in irritable bowel syndrome: a prospective, observational, 1-year follow-up study (RITMO study)
- PMID: 17217445
- DOI: 10.1111/j.1365-2036.2006.03197.x
Change over time of bowel habit in irritable bowel syndrome: a prospective, observational, 1-year follow-up study (RITMO study)
Abstract
Background: Evolution of bowel habit in irritable bowel syndrome (IBS) is not well known.
Aim: To evaluate the change over time of bowel habit in IBS patients followed-up during 1 year.
Methods: Five hundred and seventeen patients with IBS were prospectively included in an observational study with five evaluations over a 1-year period. Symptoms were recorded daily in diary cards during four 4-week periods along the study. Bristol Stool Scale (BSS) was used to define bowel habit.
Results: Four-hundred patients completed the study. Rome II showed low-moderate agreement (42%) with BSS to define bowel habit. Frequency of constipation and diarrhoea showed little changes throughout the study. Over 50% of the patients had the same bowel habit when each diary was compared with the next one. A third of patients maintained the same habit throughout the study. Most changes occurred from/to mixed or unsubtyped IBS. Only 14% of cases changed from constipation to diarrhoea or vice versa. This change was associated to female gender (OR: 2.65).
Conclusions: The frequency of constipation and diarrhoea remains relatively stable over time. Changes in IBS subtypes are common, but changes between constipation and diarrhoea are rare. Alternating IBS is more frequent in women.
Similar articles
-
Subtyping the irritable bowel syndrome by predominant bowel habit: Rome II versus Rome III.Aliment Pharmacol Ther. 2007 Sep 15;26(6):953-61. doi: 10.1111/j.1365-2036.2007.03422.x. Aliment Pharmacol Ther. 2007. PMID: 17767480
-
Short-term stability of subtypes in the irritable bowel syndrome: prospective evaluation using the Rome III classification.Aliment Pharmacol Ther. 2012 Feb;35(3):350-9. doi: 10.1111/j.1365-2036.2011.04948.x. Epub 2011 Dec 18. Aliment Pharmacol Ther. 2012. PMID: 22176384
-
Relationship of abdominal bloating to distention in irritable bowel syndrome and effect of bowel habit.Gastroenterology. 2006 Oct;131(4):1003-10. doi: 10.1053/j.gastro.2006.07.015. Epub 2006 Jul 24. Gastroenterology. 2006. PMID: 17030170
-
A symptom-based approach to making a positive diagnosis of irritable bowel syndrome with constipation.Int J Clin Pract. 2006 Jan;60(1):57-63. doi: 10.1111/j.1368-5031.2005.00744.x. Int J Clin Pract. 2006. PMID: 16409429 Review.
-
Irritable bowel syndrome.Prim Care. 2011 Sep;38(3):433-47; viii. doi: 10.1016/j.pop.2011.05.003. Prim Care. 2011. PMID: 21872090 Review.
Cited by
-
Raising Expectations in IBS-C Management.Gastroenterol Hepatol (N Y). 2025 Apr;21(4):218-231. Gastroenterol Hepatol (N Y). 2025. PMID: 40416303 Free PMC article. No abstract available.
-
Prospective diary evaluation of unexplained abdominal pain and bowel dysfunction: a population-based colonoscopy study.Dig Dis Sci. 2011 May;56(5):1444-51. doi: 10.1007/s10620-010-1468-y. Epub 2010 Nov 10. Dig Dis Sci. 2011. PMID: 21063776
-
Characterization of symptoms in irritable bowel syndrome with mixed bowel habit pattern.Neurogastroenterol Motil. 2014 Jan;26(1):36-45. doi: 10.1111/nmo.12220. Epub 2013 Aug 29. Neurogastroenterol Motil. 2014. PMID: 23991913 Free PMC article.
-
The alternative serotonin transporter promoter P2 impacts gene function in females with irritable bowel syndrome.J Cell Mol Med. 2021 Aug;25(16):8047-8061. doi: 10.1111/jcmm.16736. Epub 2021 Jun 24. J Cell Mol Med. 2021. PMID: 34165249 Free PMC article.
-
Methane and Constipation-predominant Irritable Bowel Syndrome: Entwining Pillars of Emerging Neurogastroenterology.Cureus. 2019 May 28;11(5):e4764. doi: 10.7759/cureus.4764. Cureus. 2019. PMID: 31363445 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical